查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1501271

中東和北非地區嬰兒奶粉市場－產業分析、規模、佔有率、成長、趨勢、預測（2031）- 依成分類型、依原料、依應用、依形式、依地區：（MENA）

MENA Infant Milk Formula Market - Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (MENA)
出版日期: | 出版商: Fairfield Market Research | 英文 195 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

由於消費者對嬰兒健康營養重要性的認識不斷提高以及嬰兒配方奶粉的日益普及，中東和北非地區嬰兒配方奶粉的市場規模顯著成長。嬰兒配方奶粉目的是模擬人類母乳，作為自然母乳哺育的重要替代品，可確保嬰兒獲得正常生長和發育所需的營養和能量。

嬰兒配方奶粉產業呈現強勁成長，反映出其在嬰兒發育早期階段的重要角色。該細分市場不斷成長的市場佔有率反映了對支持新生兒早期的高品質營養的需求不斷成長。

嬰兒配方奶粉產業持續擴張，主要針對從母乳哺育過渡到開始配方奶哺育的嬰兒。此細分市場的成長反映出，隨著嬰幼兒的成長及其飲食需求的變化，人們對特種營養的偏好日益增加。

嬰幼兒奶粉業務也穩定成長。此配方專為滿足幼兒的營養需求而設計，在發育里程碑時提供均衡的必需營養素攝取。

線上零售業作為中東和北非地區嬰兒配方奶粉的通路迅速發展。網路購物的便利性和可近性是其日益受到消費者歡迎的因素。該行業的成長率是所有分銷管道中最高的，預計將繼續保持上升趨勢。

本報告調查了中東和北非地區的嬰兒配方奶粉市場，並提供了市場概況，以及按成分、部署、解決方案、行業、地區和進入市場的競爭對手劃分的趨勢。

目錄

第1章 執行摘要

第2章 市場概述

  • 市場定義與細分
  • 市場動態
  • 價值鏈分析
  • 波特五力分析
  • 新冠肺炎（COVID-19）影響分析
  • 烏克蘭與俄羅斯衝突的影響
  • 經濟概況
  • PESTLE分析

第3章 2018-2024年生產與貿易統計

第4章 價格分析，2018-2024

第5章 2018-2031年GCC嬰兒配方奶粉市場前景

  • 2018-2031年GCC嬰兒配方奶粉市場前景（依成分類型、價值（十億美元）、量（MT））
  • 2018-2031年GCC嬰兒配方奶粉市場前景（依原料、價值（十億美元）、量（MT））
  • 2018-2031年GCC嬰兒配方奶粉市場前景（依應用、價值（十億美元）、量（MT））
  • 2018-2031年GCC嬰兒配方奶粉市場前景（依形態、價值（十億美元）、量（MT））
  • 2018-2031年GCC嬰兒配方奶粉市場前景（依國家、價值（十億美元）、量（MT））

第6章 2018-2031年北非嬰兒配方奶粉市場前景

  • 2018-2031年北非嬰兒配方奶粉市場前景（依成分類型、價值（十億美元）、量（MT））
  • 2018-2031年北非嬰兒配方奶粉市場前景（依原料、價值（十億美元）、量（MT））
  • 2018-2031年北非嬰兒配方奶粉市場展望（依應用、價值（十億美元）、量（MT））
  • 2018-2031年北非嬰兒配方奶粉市場前景（依形態、價值（十億美元）、量（MT））

第7章 2018-2031年其他國家嬰兒配方奶粉市場前景

  • 2018-2031年世界其他地區嬰兒配方奶粉市場前景（依成分類型、價值（十億美元）、銷售（公噸））
  • 2018-2031年其他國家嬰兒配方奶粉市場前景（依原料、價值（十億美元）、產量（公噸））
  • 2018-2031年其他國家嬰兒配方奶粉市展望（依應用、價值（十億美元）、銷售（公噸））
  • 2018-2031年其他國家嬰兒配方奶粉市場前景（依形態、價值（十億美元）、銷售（公噸））
  • 2018-2031年其他國家嬰兒配方奶粉市場前景（依國家、價值（十億美元）、銷售（公噸））

第八章 競爭態勢

  • 2024年公司市佔率分析
  • 競爭對手儀表板
  • 公司簡介
    • Groupe Danone
    • Aspen Pharmacare Holdings Limited
    • Almarai
    • Nestle S.A.
    • Behdashtkar
    • Lacto Misr
    • Nutridar Company Plc
    • Ausnutria Hyproca B.V.
    • Saudi Centre Group
    • Abbott Laboratories
    • RIRI Baby Food CO.
    • 其他

第9章 附錄

簡介目錄

The infant milk formula market in the MENA region is experiencing significant growth, driven by increasing consumer awareness about the importance of healthy nutrients for infants and the rising popularity of infant milk formula. Infant milk formula, designed to simulate human milk, serves as a crucial substitute for natural breastfeeding, ensuring that infants receive essential nutrients and energy for proper growth and development.

Market Segmentation and Growth

Starting Milk Formula The starting milk formula segment has shown robust growth, reflecting its critical role in the early stages of infant development. The segment's increasing market share highlights the demand for high-quality nutrition that supports newborns during their initial months.

Follow-On Milk Formula The follow-on milk formula segment continues to expand, catering to infants transitioning from breastfeeding or starting milk formula. This segment's growth is indicative of the increasing preference for specialized nutrition as infants grow and their dietary needs evolve.

Toddlers Milk Formula The toddlers milk formula segment is also experiencing steady growth. This formula is specifically designed to meet the nutritional needs of toddlers, ensuring they receive balanced nutrients essential for their developmental milestones.

Distribution Channels and Market Dynamics

Online Retail The online retail segment is emerging as a rapidly growing distribution channel for infant milk formula in the MENA region. The convenience and accessibility of online shopping have contributed to its rising popularity among consumers. This segment is expected to continue its upward trajectory, registering the highest growth rate among all distribution channels.

Supermarkets Supermarkets remain a significant distribution channel for infant milk formula, trusted by consumers for their wide range of products and convenient shopping experience. The supermarkets segment continues to grow, reflecting the strong consumer trust and preference for purchasing infant nutrition products from well-established retail outlets.

Chemists/Pharmacies/Drugstores Chemists, pharmacies, and drugstores are perceived as trusted sources for infant milk formula by consumers in the MENA region. This segment remains dominant, with a substantial share of the market, driven by the credibility and assurance these outlets provide to parents seeking reliable infant nutrition solutions.

Specialty Outlets Specialty outlets, including dedicated baby stores, offer a targeted approach to distributing infant milk formula. While smaller in market share compared to other channels, these outlets provide specialized advice and products, catering to parents looking for tailored nutrition solutions for their infants.

Other Distribution Channels Other distribution channels, including various local and independent stores, contribute to the overall market landscape. These channels provide additional options for consumers, supporting the widespread availability and accessibility of infant milk formula across the region.

Key Market Drivers

Rising Number of Working Women The increasing number of working women in the MENA region is a significant factor driving the growth of the infant milk formula market. As more women enter the workforce, the demand for convenient and reliable nutrition solutions for infants rises, boosting the market for infant milk formula.

Rapid Economic Development Rapid economic development in the MENA region has led to increased disposable incomes and improved living standards. This economic growth has positively impacted consumer spending on premium nutrition products, including infant milk formula, further propelling market growth.

Consumer Awareness Growing consumer awareness regarding the importance of healthy nutrition for infants is fueling the demand for infant milk formula. Parents are becoming more informed about the nutritional needs of their children and are increasingly opting for high-quality formula products that ensure proper growth and development.

Competitive Analysis

  • Behdashtkar, Lacto Misr.
  • Nutridar Company Plc.
  • Ausnutria Hyproca B.V.
  • Saudi Centre Group.
  • Abbott Laboratories.
  • RIRI Baby Food Co.
  • Groupe Danone.
  • Aspen Pharmacare Holdings Limited.
  • Almarai, Nestle S.A.
  • Other.

The MENA infant milk market is segmented as follows:

By product type

  • Starting milk formula
  • Follow-on milk formula
  • Toddlers milk formula

By distribution channel

  • Specialty store
  • Supermarkets
  • Online retail
  • Chemist/pharmacies/drugstore
  • Others

By region

  • GCC
    • Bahrain
    • Kuwait
    • Oman
    • Qatar
    • Kingdom of Saudi Arabia (KSA)
    • United Arab Emirates (UAE)
  • North Africa
    • Algeria
    • Egypt
    • Morocco
    • Tunisia
  • Rest of Middle East
    • Iraq
    • Jordan
    • Lebanon
    • Yemen

Table of Contents

1. Executive Summary

  • 1.1. MENA Infant Milk Formula Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value and Volume, 2024
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Production Output and Trade Statistics, 2018 - 2024

  • 3.1. MENA Infant Milk Formula Market Production Output, by Region, Value (US$ Bn) and Volume (MT), 2018 - 2024
    • 3.1.1. GCC
    • 3.1.2. North Africa
    • 3.1.3. Rest of Middle East and Africa

4. Price Analysis, 2018 - 2024

  • 4.1. Average Price Analysis, by Form, US$ Per MT, 2018 - 2024
  • 4.2. Prominent Factor Affecting MENA Infant Milk Formula Prices
  • 4.3. Average Price Analysis, by Region, US$ Per MT

5. GCC Infant Milk Formula Market Outlook, 2018 - 2031

  • 5.1. GCC Infant Milk Formula Market Outlook, by Ingredient Type, Value (US$ Bn) and Volume (MT), 2018 - 2031
    • 5.1.1. Key Highlights
      • 5.1.1.1. Fats & Oils
      • 5.1.1.2. Minerals
      • 5.1.1.3. Proteins
      • 5.1.1.4. Vitamins
      • 5.1.1.5. Carbohydrates
      • 5.1.1.6. Prebiotics
      • 5.1.1.7. Others (Probiotics, Nucleotides, and Emulsifiers)
  • 5.2. GCC Infant Milk Formula Market Outlook, by Source, Value (US$ Bn) and Volume (MT), 2018 - 2031
    • 5.2.1. Key Highlights
      • 5.2.1.1. Soy
      • 5.2.1.2. Protein hydrolysates
      • 5.2.1.3. Cow Milk
      • 5.2.1.4. Others (Goat milk and camel milk)
  • 5.3. GCC Infant Milk Formula Market Outlook, by Application, Value (US$ Bn) and Volume (MT), 2018 - 2031
    • 5.3.1. Key Highlights
      • 5.3.1.1. 0 to 6-month-old infants
      • 5.3.1.2. 6 to 12-month-old infants
      • 5.3.1.3. Infants over 12 months
      • 5.3.1.4. Specialty Formula
  • 5.4. GCC Infant Milk Formula Market Outlook, by Form, Value (US$ Bn) and Volume (MT), 2018 - 2031
    • 5.4.1. Key Highlights
      • 5.4.1.1. Powder
      • 5.4.1.2. Liquid & semi-liquid
  • 5.5. GCC Infant Milk Formula Market Outlook, by Country, Value (US$ Bn) and Volume (MT), 2018 - 2031
    • 5.5.1. Key Highlights
      • 5.5.1.1. Kuwait
      • 5.5.1.2. Oman
      • 5.5.1.3. Qatar
      • 5.5.1.4. Bahrain
      • 5.5.1.5. Saudi Arabia
    • 5.5.2. Key Highlights
      • 5.5.2.1. Kuwait Infant Milk Formula Market by Ingredient Type, Value (US$ Bn) and Volume (MT), 2018 - 2031
      • 5.5.2.2. Kuwait Infant Milk Formula Market by Source, Value (US$ Bn) and Volume (MT), 2018 - 2031
      • 5.5.2.3. Kuwait Infant Milk Formula Market by Application, Value (US$ Bn) and Volume (MT), 2018 - 2031
      • 5.5.2.4. Kuwait Infant Milk Formula Market by Form, Value (US$ Bn) and Volume (MT), 2018 - 2031
      • 5.5.2.5. Oman Infant Milk Formula Market by Ingredient Type, Value (US$ Bn) and Volume (MT), 2018 - 2031
      • 5.5.2.6. Oman Infant Milk Formula Market by Source, Value (US$ Bn) and Volume (MT), 2018 - 2031
      • 5.5.2.7. Oman Infant Milk Formula Market by Application, Value (US$ Bn) and Volume (MT), 2018 - 2031
      • 5.5.2.8. Oman Infant Milk Formula Market by Form, Value (US$ Bn) and Volume (MT), 2018 - 2031
      • 5.5.2.9. Qatar Infant Milk Formula Market by Ingredient Type, Value (US$ Bn) and Volume (MT), 2018 - 2031
      • 5.5.2.10. Qatar Infant Milk Formula Market by Source, Value (US$ Bn) and Volume (MT), 2018 - 2031
      • 5.5.2.11. Qatar Infant Milk Formula Market by Application, Value (US$ Bn) and Volume (MT), 2018 - 2031
      • 5.5.2.12. Qatar Infant Milk Formula Market by Form, Value (US$ Bn) and Volume (MT), 2018 - 2031
      • 5.5.2.13. Bahrain Infant Milk Formula Market by Ingredient Type, Value (US$ Bn) and Volume (MT), 2018 - 2031
      • 5.5.2.14. Bahrain Infant Milk Formula Market by Source, Value (US$ Bn) and Volume (MT), 2018 - 2031
      • 5.5.2.15. Bahrain Infant Milk Formula Market by Application, Value (US$ Bn) and Volume (MT), 2018 - 2031
      • 5.5.2.16. Bahrain Infant Milk Formula Market by Form, Value (US$ Bn) and Volume (MT), 2018 - 2031
    • 5.5.3. BPS Analysis/Market Attractiveness Analysis

6. North Africa Infant Milk Formula Market Outlook, 2018 - 2031

  • 6.1. North Africa Infant Milk Formula Market Outlook, by Ingredient Type, Value (US$ Bn) and Volume (MT), 2018 - 2031
    • 6.1.1. Key Highlights
      • 6.1.1.1. Fats & Oils
      • 6.1.1.2. Minerals
      • 6.1.1.3. Proteins
      • 6.1.1.4. Vitamins
      • 6.1.1.5. Carbohydrates
      • 6.1.1.6. Prebiotics
      • 6.1.1.7. Others (Probiotics, Nucleotides, and Emulsifiers)
  • 6.2. North Africa Infant Milk Formula Market Outlook, by Source, Value (US$ Bn) and Volume (MT), 2018 - 2031
    • 6.2.1. Key Highlights
      • 6.2.1.1. Soy
      • 6.2.1.2. Protein hydrolysates
      • 6.2.1.3. Cow Milk
      • 6.2.1.4. Others (Goat milk and camel milk)
  • 6.3. North Africa Infant Milk Formula Market Outlook, by Application, Value (US$ Bn) and Volume (MT), 2018 - 2031
    • 6.3.1. Key Highlights
      • 6.3.1.1. 0 to 6-month-old infants
      • 6.3.1.2. 6 to 12-month-old infants
      • 6.3.1.3. Infants over 12 months
      • 6.3.1.4. Specialty Formula
  • 6.4. North Africa Infant Milk Formula Market Outlook, by Form, Value (US$ Bn) and Volume (MT), 2018 - 2031
    • 6.4.1. Key Highlights
      • 6.4.1.1. Powder
      • 6.4.1.2. Liquid & semi-liquid
    • 6.4.2. BPS Analysis/Market Attractiveness Analysis

7. Rest of Middle East & Africa Infant Milk Formula Market Outlook, 2018 - 2031

  • 7.1. Rest of Middle East & Africa Infant Milk Formula Market Outlook, by Ingredient Type, Value (US$ Bn) and Volume (MT), 2018 - 2031
    • 7.1.1. Key Highlights
      • 7.1.1.1. Fats & Oils
      • 7.1.1.2. Minerals
      • 7.1.1.3. Proteins
      • 7.1.1.4. Vitamins
      • 7.1.1.5. Carbohydrates
      • 7.1.1.6. Prebiotics
      • 7.1.1.7. Others (Probiotics, Nucleotides, and Emulsifiers)
  • 7.2. Rest of Middle East & Africa Infant Milk Formula Market Outlook, by Source, Value (US$ Bn) and Volume (MT), 2018 - 2031
    • 7.2.1. Key Highlights
      • 7.2.1.1. Soy
      • 7.2.1.2. Protein hydrolysates
      • 7.2.1.3. Cow Milk
      • 7.2.1.4. Others (Goat milk and camel milk)
  • 7.3. Rest of Middle East & Africa Infant Milk Formula Market Outlook, by Application, Value (US$ Bn) and Volume (MT), 2018 - 2031
    • 7.3.1. Key Highlights
      • 7.3.1.1. 0 to 6-month-old infants
      • 7.3.1.2. 6 to 12-month-old infants
      • 7.3.1.3. Infants over 12 months
      • 7.3.1.4. Specialty Formula
  • 7.4. Rest of Middle East & Africa Infant Milk Formula Market Outlook, by Form, Value (US$ Bn) and Volume (MT), 2018 - 2031
    • 7.4.1. Key Highlights
      • 7.4.1.1. Powder
      • 7.4.1.2. Liquid & semi-liquid
  • 7.5. Rest of Middle East & Africa Infant Milk Formula Market Outlook, by Country, Value (US$ Bn) and Volume (MT), 2018 - 2031
    • 7.5.1. Key Highlights
      • 7.5.1.1. Jordan Infant Milk Formula Market by Ingredient Type, Value (US$ Bn) and Volume (MT), 2018 - 2031
      • 7.5.1.2. Jordan Infant Milk Formula Market by Source, Value (US$ Bn) and Volume (MT), 2018 - 2031
      • 7.5.1.3. Jordan Infant Milk Formula Market by Application, Value (US$ Bn) and Volume (MT), 2018 - 2031
      • 7.5.1.4. Jordan Infant Milk Formula Market by Form, Value (US$ Bn) and Volume (MT), 2018 - 2031
      • 7.5.1.5. Iraq Infant Milk Formula Market by Ingredient Type, Value (US$ Bn) and Volume (MT), 2018 - 2031
      • 7.5.1.6. Iraq Infant Milk Formula Market by Source, Value (US$ Bn) and Volume (MT), 2018 - 2031
      • 7.5.1.7. Iraq Infant Milk Formula Market by Application, Value (US$ Bn) and Volume (MT), 2018 - 2031
      • 7.5.1.8. Iraq Infant Milk Formula Market by Form, Value (US$ Bn) and Volume (MT), 2018 - 2031
      • 7.5.1.9. Lebanon Infant Milk Formula Market by Ingredient Type, Value (US$ Bn) and Volume (MT), 2018 - 2031
      • 7.5.1.10. Lebanon Infant Milk Formula Market by Source, Value (US$ Bn) and Volume (MT), 2018 - 2031
      • 7.5.1.11. Lebanon Infant Milk Formula Market by Application, Value (US$ Bn) and Volume (MT), 2018 - 2031
      • 7.5.1.12. Lebanon Infant Milk Formula Market by Form, Value (US$ Bn) and Volume (MT), 2018 - 2031
      • 7.5.1.13. Yemen Infant Milk Formula Market by Ingredient Type, Value (US$ Bn) and Volume (MT), 2018 - 2031
      • 7.5.1.14. Yemen Infant Milk Formula Market by Source, Value (US$ Bn) and Volume (MT), 2018 - 2031
      • 7.5.1.15. Yemen Infant Milk Formula Market by Application, Value (US$ Bn) and Volume (MT), 2018 - 2031
      • 7.5.1.16. Yemen Infant Milk Formula Market by Form, Value (US$ Bn) and Volume (MT), 2018 - 2031
    • 7.5.2. BPS Analysis/Market Attractiveness Analysis

8. Competitive Landscape

  • 8.1. Company Market Share Analysis, 2024
  • 8.2. Competitive Dashboard
  • 8.3. Company Profiles
    • 8.3.1. Groupe Danone
      • 8.3.1.1. Company Overview
      • 8.3.1.2. Ingredient Type Portfolio
      • 8.3.1.3. Financial Overview
      • 8.3.1.4. Business Strategies and Development
    • 8.3.2. Aspen Pharmacare Holdings Limited
      • 8.3.2.1. Company Overview
      • 8.3.2.2. Ingredient Type Portfolio
      • 8.3.2.3. Financial Overview
      • 8.3.2.4. Business Strategies and Development
    • 8.3.3. Almarai
      • 8.3.3.1. Company Overview
      • 8.3.3.2. Ingredient Type Portfolio
      • 8.3.3.3. Financial Overview
      • 8.3.3.4. Business Strategies and Development
    • 8.3.4. Nestle S.A.
      • 8.3.4.1. Company Overview
      • 8.3.4.2. Ingredient Type Portfolio
      • 8.3.4.3. Financial Overview
      • 8.3.4.4. Business Strategies and Development
    • 8.3.5. Behdashtkar
      • 8.3.5.1. Company Overview
      • 8.3.5.2. Ingredient Type Portfolio
      • 8.3.5.3. Financial Overview
      • 8.3.5.4. Business Strategies and Development
    • 8.3.6. Lacto Misr
      • 8.3.6.1. Company Overview
      • 8.3.6.2. Ingredient Type Portfolio
      • 8.3.6.3. Financial Overview
      • 8.3.6.4. Business Strategies and Development
    • 8.3.7. Nutridar Company Plc
      • 8.3.7.1. Company Overview
      • 8.3.7.2. Ingredient Type Portfolio
      • 8.3.7.3. Financial Overview
      • 8.3.7.4. Business Strategies and Development
    • 8.3.8. Ausnutria Hyproca B.V.
      • 8.3.8.1. Company Overview
      • 8.3.8.2. Ingredient Type Portfolio
      • 8.3.8.3. Financial Overview
      • 8.3.8.4. Business Strategies and Development
    • 8.3.9. Saudi Centre Group
      • 8.3.9.1. Company Overview
      • 8.3.9.2. Ingredient Type Portfolio
      • 8.3.9.3. Financial Overview
      • 8.3.9.4. Business Strategies and Development
    • 8.3.10. Abbott Laboratories
      • 8.3.10.1. Company Overview
      • 8.3.10.2. Ingredient Type Portfolio
      • 8.3.10.3. Financial Overview
      • 8.3.10.4. Business Strategies and Development
    • 8.3.11. RIRI Baby Food CO.
      • 8.3.11.1. Company Overview
      • 8.3.11.2. Ingredient Type Portfolio
      • 8.3.11.3. Financial Overview
      • 8.3.11.4. Business Strategies and Development
    • 8.3.12. Others
      • 8.3.12.1. Company Overview
      • 8.3.12.2. Ingredient Type Portfolio
      • 8.3.12.3. Financial Overview
      • 8.3.12.4. Business Strategies and Development

9. Appendix

  • 9.1. Research Methodology
  • 9.2. Report Assumptions
  • 9.3. Acronyms and Abbreviations